NHS Blood and Transplant (NHSBT) - Call for Evidence

Closed 10 Sep 2015

Opened 4 Aug 2015

Overview

The Health and Social Care Act 2012 and the Care Act 2014 have devolved functions and powers away from the Department of Health to local and Arm’s Length Bodies.

The Department has a stewardship and assurance role in respect of arm’s length bodies within the health and care system. The Department needs to ensure these organisations have appropriate functions and are performing to a high standard.

To perform this stewardship function, the Department is putting in place Triennial Reviews (TR's) of all its Arm’s Length Bodies. This includes all Executive Non-Departmental Public Bodies (ENDPBs), Advisory Non-Departmental Public Bodies (ANDPBs), Executive Agencies and Special Health Authorities (SpHA). NHS Blood and Transplant (NHSBT), a SpHA, is subject to review in 2015-2016.

The programme of reviews builds upon the approach developed by the Cabinet Office as part of their work on Public Bodies Reform.

Timeline

The Triennial Review of NHSBT commenced on the 25 June 2015 and is expected to conclude by the end of December 2015. The conclusions of the review will be announced in both Houses of Parliament and a copy of the final report will be published on the Department of Health pages on gov.uk.

Responding to the call for evidence

In order to conduct the review in an open and transparent manner and ensure that the findings are rigorous and evidence-based, the review team is seeking views from a wide range of stakeholders. The review team is interested in the views of individuals and organisations that engage with NHSBT or have a wider interest in its operations.

The call for evidence is running from Thursday 6 August 2015 to Thursday 10 September 2015. Responses can be provided by completing the online survey below.

You do not have to answer all of the questions – please feel free to answer as many or as few as you like. Your evidence should consist of objective, factual information about the impact or effect of NHSBT’s approach to health and social care. Where possible, please give specific examples. Where your evidence is relevant to other review reports, the NHSBT review team will pass your evidence over to the relevant review team(s).

Only information directly relevant to the areas of investigation will be considered. Information where relevance is not demonstrable will not be taken as evidence. The NHSBT review team is unable to respond to individual cases or consider complaints relating to NHSBT's work.  Complaints should be directed to NHSBT at enquiries@nhsbt.nhs.uk or call 0300 123 23 23.  

Patient identifiable information should not be submitted.

All submissions must be received by 23:59 hours on Thursday 10 September 2015.

 

WORKSHOPS

Interested stakeholders are also invited to attend a workshop to share their views on this Call for Evidence directly with the review team. You can book a place through the links below, which also give details on the date, time and location of the workshops.

10 August 2015               11:00 - 13:00 hours             London

https://www.eventbrite.co.uk/e/nhs-blood-and-transplant-nhs-bt-workshop-tickets-17005676436

26 August 2015               11:00 - 13:00 hours            London

https://www.eventbrite.co.uk/e/nhs-blood-and-transplant-nhs-bt-workshop-tickets-17226025506

Please note: places are limited and will be allocated on a first come first served basis.

Why We Are Consulting

The Department of Health has developed the programme of Triennial Reviews to support its stewardship and assurance function. The review will have two main stages:

  • To provide a robust challenge of the continuing need for NHSBT both in terms of the functions it performs, and the way in which these are delivered.
  • To consider NHSBT's governance, performance and capability as well as exploring opportunities for efficiencies.

 

This Call for Evidence will seek views from respondents to assist DH's consideration of both of these stages. The evidence is being gathered simultaneously for stage one and  stage two in the interests of timeliness and value for money only, and is not an expression of pre-judgment as to the outcome of stage one of the review.

The review team will take account of previous reviews and will be conscious of the altruistic nature of blood, organ, stem cell and tissue donation in their considerations.

This Call for Evidence is taking place in the context of the separate but related Accelerated Access Review (AAR). The AAR was announced by the Minister for Life Sciences, George Freeman MP, on 20 November 2014, and is anticipated to report by the end of 2015. The AAR will consider how healthcare and regulatory systems can best respond and adapt to the new landscape of innovation.

This Call for Evidence, amongst other things, seeks to test the ability of NHSBT to respond to emerging themes in the pathways for the development, assessment and adoption of innovative medicines and medical technologies.

Further details about the AAR are available at: https://engage.dh.gov.uk/acceleratedaccess/

Audiences

  • Voluntary groups
  • Community groups
  • Charities
  • Civil society
  • Advocacy or support organisations
  • Clinicians
  • Managers
  • Commissioners
  • Directors of Public Health
  • Pharmacists
  • Doctors
  • Midwives
  • Healthcare scientists
  • Foundation Trusts
  • NHS Commissioning Board
  • Clinical Commissioning Groups
  • Regulatory body
  • Academic/ Professional institution
  • Trade union
  • Royal Colleges
  • Members of the public
  • Patients
  • Patients
  • Service users
  • Suppliers
  • NHS Trust CEs
  • Public Health Organisations
  • Allied Health Professionals

Interests

  • Physical health
  • Health inequalities
  • Vascular disease
  • Public health
  • Health protection
  • Health improvement
  • Public Health England
  • Well-being
  • Health Protection Agency
  • Primary care
  • Commissioning
  • NHS Commissioning Board
  • Clinical Governance
  • Regulation